Prof Therese Kinsella, founder and chief executive of Atxa Therapeutics. Photograph: Vincent Hoban

UCD spinout drug company Atxa Therapeutics, which is developing novel therapies that tackle a deadly heart condition, is seeking to raise $30 million (...)

Ivan Coulter: “This is a company with fantastic potential.” Photograph: Dara Mac Dónaill

Ivan Coulter, the founder and former boss of Sigmoid Pharma, has been appointed chief executive of a new UCD spinout drug company that is tackling a d(...)